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ABSTRACT
Objective: There is abundant knowledge about the gravity of global load of diabetes mellitus (DM). There are conflicting reports on the cause of death 
from different parts of the world. In India, there are not enough studies to establish the cause of death in DM. To find out the mortality pattern in DM 
and non-DM (NDM) in a tertiary care teaching hospital in Eastern India.
Methods: Retrospective analysis of in-hospital mortality in a tertiary care hospital in Eastern India, from January 2012 to December 2015.
Results: There were a total of 1590 deaths of which 442 were having DM and 1148 did not have DM (NDM). Mean age of death for nondiabetics was 
66.4 years (M:F = 67.5:65.3) and that for diabetics were 62.7 years (M:F = 63.5:60.04) which was not statistically significant (p=0.9) though diabetics 
died younger by 4 years. On analyzing the specific cause of death, coronary artery disease (CAD) was 14.71% in DM and 1.57% in NDM (p=0.0001). 
Chronic kidney disease (CKD) was 18.55% in DM and 1.92% in NDM (p=0.0001). Congestive heart failure was 7.27% in DM and 1.83% in NDM 
(p=0.0001). CVA was 13.57% in DM and 1.66% in NDM (p=0.0001). Infection was the most common cause of death (39.37%) in DM, but in NDM also 
this was quite high 34.41% (p=0.21). The death due to CVA in DM was more in hemorrhage as compared to ischemic (p=0.00001).
Conclusion: We found causes of death in DM were an infection, CKD, CAD, CVA, and CHF in descending order in this part of the world. The diabetes 
patients had lesser hospital stay than nondiabetes patients (p=0.009).
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INTRODUCTION
Diabetes mellitus (DM) is the leading cause of morbidity and mortality 
in India [1,2]. A recent national survey of diabetes conducted in six major 
cities in India: New Delhi, Chennai, Bangalore, Hyderabad, Kolkata, and 
Mumbai gave a prevalence of diabetes and impaired glucose tolerance 
in urban adults of 12.1% and 14.0%, respectively [1]. According to the 
World Health Organization estimates, India had nearly 19.4 million 
adults with diabetes in 1995 and is projected to have 57.2 million by 
2025 [3]. Of the estimated 25 million persons with diabetes in India 
in 1999, only 3.6 million received pharmacological treatment [4]. The 
Bangalore Urban Diabetes Study estimated that the annual direct cost 
for diabetes care in 1998 was about US$ 191, and the mean direct cost 
per hospitalization for a diabetes-related event was about US$ 208 [5]. 
The per capita expenditure on health care in India is only 6.4% of the 
average world spending on health, while India accounts for 23.5% 
of the world’s disability-adjusted life years lost due to diabetes [6]. 
Epidemiologic studies on mortality in DM in the Western countries and 
Japan showed that cardiovascular and cerebrovascular diseases are the 
leading causes of death [7-14], while no such information is available 
from India and other developing countries. A few earlier hospital based 
reports from India had reported infection and chronic renal failure as 
the leading causes of death in hospitalized patients [15,16]. Due to scant 
information on mortality in diabetes from this part of the world where 
the prevalence of diabetes is higher, we collected and analyzed data 
from our hospital records over a 4 years period.
METHODS
In this retrospective study, all the information was collected from 
inpatients’ medical records at IMS and SUM Hospital, Bhubaneswar, 
India, from January 2012 to December 2015 and rerecorded in a 
structured format. This study is approved from our Institutional Ethics 
Committee. SUM Hospital is a large multidisciplinary teaching hospital 
in Eastern India with over 1 million outpatients, and 1,65,388 were 
admitted during the study period. All death case files (1590) were 
retrieved. Each file was scrutinized for confirmation of the diagnosis 
of DM and its reason(s) for admission and secondary/tertiary disease 
or diabetes related complications contributing to death [17]. Data 
collected were age, sex, blood glucose at presentation, evidence of 
micro- and macrovascular complications, concurrent illness and time 
in hospital preceding death. Cause of death was evaluated with respect 
to (1) presence of diabetes-related complications and (2) associated 
illnesses. Some patients died of diseases unrelated to diabetes such as 
malignancy (other than carcinoma pancreas), gastrointestinal bleeding, 
and hepatic failure/cirrhosis. These were classified as diabetes 
unrelated deaths. The cause of death (single or multiple) was compared 
with nondiabetic patients died during this period.
Statistical analysis
The Statistical Program for the Social Sciences, version 7.5, PC Windows 
package was used for data analysis. In addition to descriptive statistics, 
the χ2-test was used to assess the association between categorical 
variables and t-test for comparison among continuous variables. Two-
tailed p values were calculated, and PB/0.05 was taken as statistically 
significant.
RESULT
In this 4-year retrospective study, it was revealed that 1590 adult 
patients died in this hospital out of total 1,65,388 adult admissions. 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Out of 1590 deaths, 442 patients had diabetes and rest did not have 
diabetes. A t-test was analyzed between the patients died with 
diabetes and without diabetes and found not significant as it is equally 
distributed in both groups (p=0.9, Table 1). It was observed that the 
death of patients in both diabetes and nondiabetes groups were on 
increasing order according to increasing age (Fig. 1).
All patients died with diabetes were classified it into two groups, 
i.e., with diabetes-related disease (DRD) (377 patients) and diabetes 
non-related diseases (DNRD) (65 patients). From t-test, it was revealed 
that it is highly significant (p=0.02). Hence, the patients with diabetes 
have much higher chance of death if they have DRD compared to those 
with DNRD in the same age groups (Table 2). The diabetes patients with 
diabetes complications had much higher chance of death compared to 
those with non DRD in all the age group (Fig. 2).
We also tried to check for any significant difference in sex for NDM as 
far as mortality for a particular complication is concerned. However, we 
found all the complications leading to death were equitably distributed 
in both sexes expect infection. In the case of infection, M: F was 117:53 
which was statistically significant at p=0.03 (Table 3).
Our study revealed that the diabetes patients with more complications 
had more chance of death compared to those having less complication. 
We had 17.87% deaths with one complication, 35.29% deaths with 
two complications and 46.83% with three or more complications. 
The hospital stay before death also diminishes as the number of 
complications increased (Table 4).
There were 1148 deaths without diabetes, with a mean age at 
death 66.4 years (M:F - 67.5:65.3). Contributory factors were 
infections - 34.39% (average age 69.2 years), stroke - 1.66% (average 
age 68.7 years), CKD - 1.92% (average age 61.2 years), coronary artery 
disease (CAD) - 1.57% (average age 68.1 years), heart Failure - 1.83% 
(average age 71.2 years). Death due to other diseases such as 
malignancy, seizures, burns, and accidents were 31.71%. The diabetes 
patients died in less hospital stay period than nondiabetes patients, it 
was statistically significant as p=0.009 (Table 5).
In those having DM, contributory factors for death were 
infections - 39.37% (M-63%, F-37%) average age 59.8 years, 
CKD - 18.55% (M-76%, F-24%) average age 63.9 years, CAD  - 14.7% 
(M-66%, F-34%) average age 63.58 years, stroke - 13.57% (M-70%, 
F-30%) average age was 65.3 years, heart failure - 7.24% (M-76%, 
Fig. 1: Bar diagram of death of patients with diabetes and 
nondiabetes according to age group
Fig. 2: Bar diagram death of diabetes patients with diabetes-
related and non-related complications




DM (N=442) NDM (N=1148)
Male Female Total (%) Male Female Total (%)
15-24 9 7 16 (3.62) 36 25 61 (5.31)
25-34 16 5 21 (4.75) 64 46 110 (9.58)
35-44 25 2 27 (6.11) 72 58 130 (11.32)
45-54 53 36 89 (20.14) 96 79 175 (15.24)
55-64 81 49 130 (29.41) 181 94 275 (23.95)
>65 110 49 159 (35.97) 263 134 397 (34.58)
Total 294 148 442 (100.00) 712 436 1148 (100.00)
DM: Diabetes mellitus, NDM: Nondiabetes mellitus




Male Female Total (%) Male Female Total (%)
15-24 7 5 12 (2.71) 1 2 3 (0.68)
25-34 5 4 9 (2.04) 2 2 4 (0.90)
35-44 32 15 47 (10.63) 6 3 9 (2.04)
45-54 56 29 85 (19.23) 5 4 9 (2.04)
55-64 71 30 101 (22.85) 6 5 9 (2.04)
>65 83 40 123 (27.83) 22 7 29 (6.56)
Total 254 123 377 (85.29) 42 23 65 (14.71)
DRD: Diabetes related diseases, DNRD: Diabetes non-related diseases
Table 3: Death without diabetics (N=1148)
Disease Sex Number of death Average age at 
death
p value
CKD M 62 62.81±13.22 0.29
F 20 62.12552±14.28
CAD M 42 64.38±14.17 0.78
F 23 63.23±14.15
CVA M 36 63.73±10.21 0.66
F 24 62.52±12.83
CHF M 18 68.03±15.5 0.56
F 14 66.39±17.6
Infection M 117 61.92±12.24 0.03
F 53 61.23±13.45
CKD: Chronic kidney disease, CAD: Coronary artery disease, 
CVA: Cerebrovascular disease, CHF: Congestive heart failure
Table 4: Duration of hospital stay in diabetics with number of 
complication
Complication Number of 
death (%)
Hospital stay in days
One complication 79 (17.87) 25
Two complication 156 (35.29) 9
Three or more complication 207 (46.83) 4
Total 442 (100) -
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F-24%) average age 67.31 years, deaths not related to diabetes were 
14.7%. The percentage of overall deaths due to leading causes in 
diabetes and nondiabetes was compared with t-test and it was revealed 
highly significant (p=0.01, Table 5).
The death of DM due to CVA was classified into two groups, ischemic 
and hemorrhagic with respect to age group. It was revealed with t-test, 
i.e. there was no any significant between groups (p=0.18). Whereas in 
total, irrespective of the age, with χ2 it was revealed that death due to 
hemorrhage was more as compared to ischemic (p=0.00001, Table 6).
DISCUSSION
Mortality in diabetes is influenced by long-term vascular complications 
of diabetes, uncontrolled hyperglycemia; its metabolic sequelae, and/or 
treatment induced hypoglycemia. In most countries, mortality records 
under report diabetes as the primary, or underlying/contributory 
disease causing death [9,18-21]. Analyses of US death certificates 
(1999) indicate that the presence of diabetes is recorded in only 40-50% 
and is represented as a contributory cause of death in only 10-15% 
patients [22]. Factors contributing to increased mortality trends in 
developing countries include lack of awareness, poor drug compliance, 
inadequate secondary/tertiary hospital care facilities, unorganized 
referral system, poor patient transport service, affordability, and 
availability of effective drugs. Our study is an important addition to 
the scant literature in the mortality statistics of Indians with diabetes. 
Earlier data from other centers in India have shown that diabetes 
accounts for 2.5-10% of all deaths in hospital [15,23,24]. This is much 
higher with our observation of a 27.8% overall death rate in diabetes 
patients. It is higher as compare to other studies of India also. People 
in the eastern zone of the country have very poor drug compliance and 
they reach a secondary or tertiary care center only after landing up in 
complications [25]. Study from Netherlands reported less death with 
diabetes [26], while that from Canada is still lower [16].
We recorded the highest number of deaths in the age group of >65 years 
in patients with diabetes. Infection (39.37%) accounted for the largest 
number of deaths in diabetes in our study. A high prevalence of infection-
related mortality has been reported in other studies from India. Zargar 
et al. from Srinagar, Kashmir Valley reported 33.8% of all deaths 
related to infection [15]. In another Indian study, Das et al. from Orissa 
made a similar observation on infection related mortality (33.7%) in 
diabetes [23]. The infection has also been noted as the leading cause 
of death in diabetic hospital inpatients from China and Brazil [27,28]. 
Of the infections, bronchopneumonia with pulmonary tuberculosis 
accounted for 19% of all diabetes deaths. Most of these patients were 
chronic bidi/cigarette smokers and had a history of repeated chest 
infection in preceding years. In Brunei, diabetes (67%) was the most 
common predisposing factor for melloidosis, a serious pulmonary 
infection with high mortality [29]. In a population-based mortality 
study in the US, diabetes conferred 4 times increased mortality risk 
in the younger age group and almost twice mortality risk in the older 
age group from pneumonia and influenza [30]. Mortality and morbidity 
increased significantly among people with diabetes during epidemics of 
pneumonia and influenza [31,32].
Individuals with diabetes carry a higher risk of severe chest infection 
through altered defense mechanisms from hyperglycemia, obesity 
and/or the effect of neuropathy and impaired tissue perfusion [33,34]. 
Diabetic foot and related sepsis were the second most common form 
of infection-related mortality. The habit of barefoot walking, working 
in fields in the country side and poor foot care predispose diabetics 
to recurrent trauma and infection. Poor socioeconomic status, lack of 
proper awareness of the disease and delayed presentation could be 
other important contributory factors. After infection, the second most 
common DRD was chronic kidney disease (CKD). The incidence rate 
was 18.55% in our study. CAD was the next common cause of death 
14.71% in diabetes. Various clinical and epidemiological investigations 
from the West provide unequivocal evidence for cardiovascular (60%) 
and cerebrovascular diseases (15%) as the leading causes of mortality 
in diabetes [7-13]. Out of 9 patients presenting with DKA in our 
study, most of them died due to delayed admission and complicating 
infections. In other Indian studies, deaths from DKA ranged from 6.7 to 
20% [14,35]. In a study, it was revealed that uncontrolled diabetes for the 
first few years can cause acute cardiac and renal complications which 
are life-threatening [36]. Comparison of blood glucose at presenting 
and follow-up in association with education and counseling led to 
betterment of disease, outcome. Most of the diabetic hyperosmolar 
coma deaths occurred with infection. The death due to CVA in DM was 
more in hemorrhage as compared to ischemic (p=0.00001). In another 
study, it was revealed that efforts are needed to increase the medication 
adherence of these patients so they can realize the full benefits of 
prescribed therapies [37]. This is an in-hospital study covering only 
those who died in a hospital. Hence, this does not reflect any scenario 
in the society at large population. A total of 1587 deaths in 4 years 
(average yearly adult deaths 397) against approx 42000 admissions per 
year are too low. This is probably due to very liberal policy of admission, 
this being a new upcoming hospital..
CONCLUSION
There has been an increase in diabetes-related mortality over the past 
decade. Unlike most of the western studies where CAD and stroke were 
the leading causes of death in diabetics, in our study, we found infection 
and CKD to be the leading causes. The overall increased mortality 
appears also attributable to the prevalence of cardiovascular diseases. 
Therefore, policy makers should pay more attentions to primary 
prevention of diabetes to reduce the incidence of death. While placing 
priority on the prevention of cardiovascular diseases, awareness must 
also be increased regarding any form of infection which should alarm 
the patient for medical attention to reduce the burden of diabetes-
Table 5: Leading cause of death
Disease Diabetics (442) Non-diabetics (1148)
Diabetic related 
disease
NP % AHS NP % AHS
Infection 174 39.37 6 395 34.41 11
CAD 65 14.71 2 18 1.57 7
CKD 82 18.55 7 22 1.92 20
CHF 32 7.24 7 21 1.83 10
CVA 60 13.57 2 19 1.66 18
DKA 9 2.04 6 - - -
Hyperosmolar 
coma
5 1.13 4 - -






9 2.04 14 98 8.54 12
Malignancy 5 1.13 56 166 14.46 27
Others 17 3.85 23 364 31.71 36
NP: Number of patients, AHS: Average hospital stay, CAD: Coronary artery 
disease, CKD: Chronic kidney disease, CHF: Congestive heart failure, 
CVA: Cerebrovascular disease, DKA: Diabetic ketoacidosis 
Table 6: Comparison of type of CVA in fatal cases of DM
S. No Age Ischemic Hemorrhagic p value
1 40-50 2 5 0.1845
2 51-60 6 24
3 61-70 7 10
4 71-80 5 7
5 81-90 2 2
Total 22 48 0.00001
CVA: Cerebrovascular disease, DM: Diabetes mellitus 
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related deaths. It is also important to make the population aware of 
early screening for diabetes and ensure good glycemic control from the 
early stage to prevent/delay development of CKD.
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